Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 6;127(1):157-70.
doi: 10.1016/j.cell.2006.08.034.

RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival

Yuchen Chien  1 , Sungchan Kim, Ron Bumeister, Yueh-Ming Loo, Sung Won Kwon, Cynthia L Johnson, Mirey G Balakireva, Yves Romeo, Levy Kopelovich, Michael Gale Jr, Charles Yeaman, Jacques H Camonis, Yingming Zhao, Michael A White
Affiliations
Free article

RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival

Yuchen Chien et al. Cell. .
Free article

Abstract

The monomeric RalGTPases, RalA and RalB are recognized as components of a regulatory framework supporting tumorigenic transformation. Specifically, RalB is required to suppress apoptotic checkpoint activation, the mechanistic basis of which is unknown. Reported effector proteins of RalB include the Sec5 component of the exocyst, an octameric protein complex implicated in tethering of vesicles to membranes. Surprisingly, we find that the RalB/Sec5 effector complex directly recruits and activates the atypical IkappaB kinase family member TBK1. In cancer cells, constitutive engagement of this pathway, via chronic RalB activation, restricts initiation of apoptotic programs typically engaged in the context of oncogenic stress. Although dispensable for survival in a nontumorigenic context, this pathway helps mount an innate immune response to virus exposure. These observations define the mechanistic contribution of RalGTPases to cancer cell survival and reveal the RalB/Sec5 effector complex as a component of TBK1-dependent innate immune signaling.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

  • A signalling cascade for Ral.
    Wu Y, Reiner DJ. Wu Y, et al. Small GTPases. 2022 Jan;13(1):128-135. doi: 10.1080/21541248.2021.1917953. Epub 2021 May 6. Small GTPases. 2022. PMID: 33956571 Free PMC article. Review.
  • Mechanism of endogenous regulation of the type I interferon response by suppressor of IκB kinase epsilon (SIKE), a novel substrate of TANK-binding kinase 1 (TBK1).
    Marion JD, Roberts CF, Call RJ, Forbes JL, Nelson KT, Bell JE, Bell JK. Marion JD, et al. J Biol Chem. 2013 Jun 21;288(25):18612-23. doi: 10.1074/jbc.M112.440859. Epub 2013 May 6. J Biol Chem. 2013. PMID: 23649622 Free PMC article.
  • Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
    Khurana N, Dodhiawala PB, Bulle A, Lim KH. Khurana N, et al. Cancers (Basel). 2020 Sep 19;12(9):2675. doi: 10.3390/cancers12092675. Cancers (Basel). 2020. PMID: 32961746 Free PMC article. Review.
  • TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss.
    Hu L, Xie H, Liu X, Potjewyd F, James LI, Wilkerson EM, Herring LE, Xie L, Chen X, Cabrera JC, Hong K, Liao C, Tan X, Baldwin AS, Gong K, Zhang Q. Hu L, et al. Cancer Discov. 2020 Mar;10(3):460-475. doi: 10.1158/2159-8290.CD-19-0837. Epub 2019 Dec 6. Cancer Discov. 2020. PMID: 31810986 Free PMC article.
  • Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.
    McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Monnereau A, Link BK, Vermeulen RCH, Ansell SM, Maria A, Diver WR, Melbye M, Ojesina AI, Kraft P, Boffetta P, Clavel J, Giovannucci E, Besson CM, Canzian F, Travis RC, Vineis P, Weiderpass E, Montalvan R, Wang Z, Yeager M, Becker N, Benavente Y, Brennan P, Foretova L, Maynadie M, Nieters A, de Sanjose S, Staines A, Conde L, Riby J, Glimelius B, Hjalgrim H, Pradhan N, Feldman AL, Novak AJ, Lawrence C, Bassig BA, Lan Q, Zheng T, North KE, Tinker LF, Cozen W, Severson RK, Hofmann JN, Zhang Y, Jackson RD, Morton LM, Purdue MP, Chatterjee N, Offit K, Cerhan JR, Chanock SJ, Rothman N, Vijai J, Goldin LR, Skibola CF, Caporaso NE. McMaster ML, et al. Nat Commun. 2018 Oct 10;9(1):4182. doi: 10.1038/s41467-018-06541-2. Nat Commun. 2018. PMID: 30305637 Free PMC article.
See all "Cited by" articles

Publication types

MeSH terms